Session — ASN Events
clear
Downsizing promiscuous Bim BH3 domain into a potent, cell-permeable, selective inhibitor of oncogenic Bcl2A1 and Mcl-1 proteins Semi-synthesis of Homogeneous Glycoproteins  The power of chemoselectivity: Functional protein-conjugates for intra- and extracellular targeting  CXMS Analysis for Complex Protein Structures and Protein-Protein Interactions  Short arginine analogs: peptide synthesis and prediction of biological effects Validating the relaxin-3 neuropeptide receptor, RXFP3, as a promising target for the treatment of obesity and depression  Development of granulin derived peptides as wound healing agents  Discovery and biosynthesis of ribosomally synthesized and posttranslationally modified peptides (RiPPs) Targeting Sodium Channels for the Treatment of Pain Peptide therapeutics for metabolic disorders  Peptide-based surface-fill hydrogel facilitates miRNA delivery to treat mesothelioma Studying the molecular pharmacology of peptide- and protein-activated receptors Data Reduction and Visualization Technologies for the Design & Optimization of Therapeutic Peptides  Enhancing or manipulating oxidative protein folding by selenium chemistry  Tools and methods for probing the biology of tryptophan C-mannosylation  Customizing macromolecules through chemical ligation  Sugars & proteins: towards a synthetic biology Mechanisms of nonribosomal peptide diversification  A Systematic Approach to Targeting Protein Surfaces Cell penetrating peptides to increase membrane permeability of larger cyclic peptides as inhibitors for protein-protein interactions  Optical control of protein domain conformation and cell signaling  Towards liquid biopsy screening for esophageal adenocarcinoma Alzheimer’s Disease – an Assay Odyssey